<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (NHL) are etiologically <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In Egypt, we previously reported an association of increased NHL risk with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C virus (HCV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Our present aim is to assess the association between HCV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and histological subtypes of NHL </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We conducted a case-control study at the National <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Institute of Cairo University </plain></SENT>
<SENT sid="4" pm="."><plain>Cases with NHL (n = 486) were matched to controls (n = 786) who were orthopedic patients from the same referral regions </plain></SENT>
<SENT sid="5" pm="."><plain>Participants provided a blood sample for HCV markers (anti-HCV, HCV <z:chebi fb="40" ids="33697">RNA</z:chebi>) and answered a questionnaire on possible risk factors </plain></SENT>
<SENT sid="6" pm="."><plain>Case-control differences were assessed by odds ratios and 95% confidence intervals from logistic regression analysis </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Cases with diffuse large B cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 146), <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (n = 58), marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 24), follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 23), and mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 16) were recruited </plain></SENT>
<SENT sid="8" pm="."><plain>HCV <z:chebi fb="40" ids="33697">RNA</z:chebi> prevalence was 27% in controls and 26%-48% in the NHL subgroups: it was associated (p &lt; 0.001) with diffuse large B cell, marginal zone, and follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with odds ratios of 3.2, 4.4, and 3.3, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: HCV is a risk factor for diffuse large B cell, marginal zone, and follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> in Egypt </plain></SENT>
</text></document>